New Key Statistics Module, Z-Score and F-Score
NAS:CNTA Key Ratios
| Market Cap $ M | 981.51 |
| Enterprise Value $ M | 837.47 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.68 |
| Price/Sales | 122.65 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 6.00 |
| EPS (TTM) $ | -1.56 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.04 |
| EV-to-EBITDA | -5.06 |
| PEG | -- |
| Shares Outstanding M | 111.66 |
| Net Margin (%) | -2,204.66 |
| Operating Margin % | -2,499.39 |
| Pre-tax Margin (%) | -2,570.28 |
| Quick Ratio | 8.00 |
| Current Ratio | 8.00 |
| ROA % (ttm) | -38.18 |
| ROE % (ttm) | -53.89 |
| ROIC % (ttm) | -326.22 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.26 |
CNTA Number of Guru Trades
CNTA Volume of Guru Trades
Gurus Latest Trades with NAS:CNTA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CNTA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Centessa Pharmaceuticals PLC Insider Transactions
No Available Data
News about NAS:CNTA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers